Literature DB >> 21602880

Integrin-linked kinase: not so 'pseudo' after all.

G E Hannigan1, P C McDonald, M P Walsh, S Dedhar.   

Abstract

Integrin-linked kinase (ILK) is a highly evolutionarily conserved intracellular protein that was originally identified as an integrin-interacting protein, and extensive genetic and biochemical studies have shown that ILK expression is vital during both embryonic development and tissue homeostasis. At the cellular and tissue levels, ILK regulates signaling pathways for cell adhesion-mediated cell survival (anoikis), apoptosis, proliferation and mitosis, migration, invasion, and vascularization and tumor angiogenesis. ILK also has central roles in cardiac and smooth-muscle contractility, and ILK dysregulation causes cardiomyopathies in humans. ILK protein levels are increased in several human cancers and often the expression level predicts poor patient outcome. Abundant evidence has accumulated suggesting that, of the diverse functions of ILK, some may require kinase activity whereas others depend on protein-protein interactions and are, therefore, independent of kinase activity. However, the past several years have seen an ongoing debate about whether ILK indeed functions as a protein serine/threonine kinase. This debate centers on the atypical protein kinase domain of ILK, which lacks some amino-acid residues thought to be essential for phosphotransferase activity. However, similar deficiencies are present in the catalytic domains of other kinases now known to possess protein kinase activity. Numerous studies have shown that ILK phosphorylates peptide substrates in vitro, corresponding to ILK-mediated phosphorylations in intact cells, and a recent report characterizing in vitro phosphotransferase activity of highly purified, full-length ILK, accompanied by detailed enzyme kinetic analyses, shows that, at least in vitro, ILK is a bona fide protein kinase. However, several genetic studies suggest that, not all biological functions of ILK require kinase activity, and that it can function as an adaptor/scaffold protein. Here, we review evidence for and against ILK being an active kinase, and provide a framework for strategies to further analyze the kinase and adaptor functions of ILK in different cellular contexts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602880     DOI: 10.1038/onc.2011.177

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  63 in total

1.  Effect of uraemia on endothelial cell damage is mediated by the integrin linked kinase pathway.

Authors:  Andrea García-Jérez; Alicia Luengo; Julia Carracedo; Rafael Ramírez-Chamond; Diego Rodriguez-Puyol; Manuel Rodriguez-Puyol; Laura Calleros
Journal:  J Physiol       Date:  2014-12-18       Impact factor: 5.182

2.  Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle.

Authors:  Cindy Sutherland; Michael P Walsh
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

3.  LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Authors:  Julie Devallière; Mathias Chatelais; Juliette Fitau; Nathalie Gérard; Philippe Hulin; Laura Velazquez; Christopher E Turner; Béatrice Charreau
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

Review 4.  The role of actin filament dynamics in the myogenic response of cerebral resistance arteries.

Authors:  Michael P Walsh; William C Cole
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

Review 5.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

6.  PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.

Authors:  Ridwan Alam; Chad R Schultz; William A Golembieski; Laila M Poisson; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2013-02-03       Impact factor: 12.300

7.  Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases.

Authors:  Ben Davidson; Arild Holth; Mai T P Nguyen; Claes G Tropé; Chuanyue Wu
Journal:  Gynecol Oncol       Date:  2012-10-22       Impact factor: 5.482

Review 8.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

9.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.

Authors:  Umadevi V Wesley; Raghu Vemuganti; Emine R Ayvaci; Robert J Dempsey
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

10.  Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells.

Authors:  P-C Chu; M-C Yang; S K Kulp; S B Salunke; L E Himmel; C-S Fang; A M Jadhav; Y-S Shan; C-T Lee; M-D Lai; L A Shirley; T Bekaii-Saab; C-S Chen
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.